"In Europe, we are in the final stages before submitting" clinical trial data to the European Medicines Agency (EMA) and validation is expected to take between four and six weeks, said the co-founder and director of BioNTech. . 

The German laboratory BioNTech is about to file in the EU an authorization request for the use of its vaccine against Covid-19 in children aged 12 to 15 years, making possible an approval from June.

"In Europe, we are in the final stages before submitting" the clinical trial data to the European Medicines Agency (EMA) and validation is expected to take between four and six weeks, said the co-founder and director of the company in German magazine

Spiegel.

>> LIVE -

 Coronavirus: follow the evolution of the situation Thursday, April 29

>> More information to follow ...